远大医药集团有限公司（股票代码：00512）于2026年6月3日发布本公司截至2026年5月31日的股份变动月报表。报告显示，远大医药在此期间未进行新增发行、购回、注销或库藏股活动，股本保持稳定。
根据公告，截至5月末，公司法定及注册股本维持为100,000,000,000股普通股，面值每股港币0.01元，相当于法定/注册股本总额港币10亿元。报告期初和期末，已发行股份（不包括库存股份）均为3,549,571,148股，期末并无库存股份。
公告同时指出，期权与股权激励计划并无调整，也未出现新增认股权证或可转债发行情况。公司确认，所有与上市条例、法律及其他监管规定相关的要求均已得到遵守。
本次公告由公司秘书傅天忠签署。根据月报信息，截至5月31日，公司股本总数保持不变，未有股份发行及回购活动。公司将继续密切关注市场情况，并及时履行信息披露义务与监管合规要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.